(0.26%) 5 144.75 points
(0.14%) 38 494 points
(0.42%) 17 921 points
(-0.91%) $83.09
(0.31%) $1.929
(-0.04%) $2 346.30
(0.06%) $27.55
(2.23%) $942.65
(-0.17%) $0.933
(-0.15%) $11.01
(-0.34%) $0.798
(1.30%) $93.07
@ $43.60
发出时间: 15 Feb 2024 @ 04:55
回报率: -35.00%
上一信号: Feb 15 - 01:37
上一信号:
回报率: 0.58 %
Live Chart Being Loaded With Signals
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery...
Stats | |
---|---|
今日成交量 | 446 577 |
平均成交量 | 770 438 |
市值 | 2.22B |
EPS | $0 ( 2024-04-25 ) |
下一个收益日期 | ( $0.550 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 33.74 |
ATR14 | $0.0150 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | De Witte Jan | Buy | 41 414 | Restricted Stock Units |
2024-03-11 | De Witte Jan | Sell | 205 | Restricted Stock Units |
2024-03-11 | De Witte Jan | Buy | 95 664 | Non- Qualified Stock Option (right to buy) |
2024-03-11 | De Witte Jan | Buy | 205 | Common Stock |
2024-03-11 | De Witte Jan | Sell | 205 | Common Stock |
INSIDER POWER |
---|
80.45 |
Last 97 transactions |
Buy: 599 911 | Sell: 62 631 |
音量 相关性
Integra Lifesciences 相关性 - 货币/商品
Integra Lifesciences 财务报表
Annual | 2023 |
营收: | $1.54B |
毛利润: | $888.39M (57.63 %) |
EPS: | $0.850 |
FY | 2023 |
营收: | $1.54B |
毛利润: | $888.39M (57.63 %) |
EPS: | $0.850 |
FY | 2022 |
营收: | $1.56B |
毛利润: | $970.31M (62.29 %) |
EPS: | $2.18 |
FY | 2021 |
营收: | $1.54B |
毛利润: | $944.64M (61.24 %) |
EPS: | $1.996 |
Financial Reports:
No articles found.
Integra Lifesciences
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。